Skip to content

Resolute Integrity™ RSINT25014WRecalls & reported problems

Medtronic, Inc. · Stent RSINT25014W MicroTrac 2.50X14OTW · Class 3 · Implant

All models of Resolute Integrity (52)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00613994793317), received between Jan 15, 2018 and Jan 15, 2018 — classified as 1 malfunction.

The most frequently reported specific device problem is “Inflation Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Inflation Problem1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJan 15, 2018Inflation Problem; Inflation Problem

    THE PHYSICIAN INTENDED TO USE A RESOLUTE INTEGRITY DRUG ELUTING STENT DEVICE. IT IS REPORTED THAT THE DEVICE MALFUNCTIONED AND BALLOON WOULD NOT INFLATE AND WAS THEN PULLED OUT; NOTHING DETACHED. NO PATIENT INJURY IS REPORTED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 7188807 ↗

Other Coronary drug-eluting stent devices

All Coronary drug-eluting stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page